Shanghai RAAS Blood Products Co Ltd
SZSE:002252

Watchlist Manager
Shanghai RAAS Blood Products Co Ltd Logo
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Watchlist
Price: 6.89 CNY -0.86% Market Closed
Market Cap: 45.7B CNY

Wall Street
Price Targets

Price Targets Summary
Shanghai RAAS Blood Products Co Ltd

Wall Street analysts forecast Shanghai RAAS Blood Products Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai RAAS Blood Products Co Ltd is 7.55 CNY with a low forecast of 6.87 CNY and a high forecast of 8.4 CNY.

Lowest
Price Target
6.87 CNY
0% Downside
Average
Price Target
7.55 CNY
10% Upside
Highest
Price Target
8.4 CNY
22% Upside
Shanghai RAAS Blood Products Co Ltd Competitors:
Price Targets
ALT
Altimmune Inc
222% Upside
ARGX
argenx SE
38% Upside
SIGHT
Gensight Biologics SA
71% Upside
BSLN
Basilea Pharmaceutica AG
75% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
4% Downside
NGNE
Neurogene Inc
116% Upside
MRNA
Moderna Inc
79% Upside
MRUS
Merus NV
67% Upside

Revenue
Forecast

Revenue Estimate
Shanghai RAAS Blood Products Co Ltd

For the last 8 years the compound annual growth rate for Shanghai RAAS Blood Products Co Ltd's revenue is 17%. The projected CAGR for the next 2 years is 9%.

17%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shanghai RAAS Blood Products Co Ltd

For the last 8 years the compound annual growth rate for Shanghai RAAS Blood Products Co Ltd's operating income is 9%. The projected CAGR for the next 3 years is 13%.

9%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Net Income
Forecast

Net Income Estimate
Shanghai RAAS Blood Products Co Ltd

For the last 8 years the compound annual growth rate for Shanghai RAAS Blood Products Co Ltd's net income is 4%. The projected CAGR for the next 2 years is 16%.

4%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-22%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai RAAS Blood Products Co Ltd's stock price target?
Price Target
7.55 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai RAAS Blood Products Co Ltd is 7.55 CNY with a low forecast of 6.87 CNY and a high forecast of 8.4 CNY.

What is Shanghai RAAS Blood Products Co Ltd's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Shanghai RAAS Blood Products Co Ltd's revenue is 17%. The projected CAGR for the next 2 years is 9%.

What is Shanghai RAAS Blood Products Co Ltd's Operating Income forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Shanghai RAAS Blood Products Co Ltd's operating income is 9%. The projected CAGR for the next 3 years is 13%.

What is Shanghai RAAS Blood Products Co Ltd's Net Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Shanghai RAAS Blood Products Co Ltd's net income is 4%. The projected CAGR for the next 2 years is 16%.

Back to Top